{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T06:29:46Z","timestamp":1655360986466},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.transproceed.2008.03.014","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T11:20:19Z","timestamp":1209554419000},"page":"740-742","source":"Crossref","is-referenced-by-count":5,"title":["Angiotensin-Converting Enzyme Inhibitors After Renal Transplantation"],"prefix":"10.1016","volume":"40","author":[{"given":"P.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Felgueiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2008.03.014_bib1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2008.03.014_bib2","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomized placebo-controlled trial of the effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2008.03.014_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2008.03.014_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2008.03.014_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2008.03.014_bib6","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfh462","article-title":"Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy","volume":"19","author":"Artz","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2008.03.014_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/ndt\/gfg593","article-title":"The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy","volume":"19","author":"Zaltzman","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2008.03.014_bib8","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/00007890-199612150-00018","article-title":"Antihypertensive drug treatment in chronic renal allograft rejection in the rat","volume":"62","author":"Benediktsson","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.03.014_bib9","first-page":"S34","article-title":"Post-transplant hypertension and chronic renal allograft failure","volume":"52","author":"Paul","year":"1995","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.transproceed.2008.03.014_bib10","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2008.03.014_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2008.03.014_bib12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1034\/j.1399-0012.2001.150611.x","article-title":"Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial","volume":"15","author":"Midtvedt","year":"2001","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2008.03.014_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00007890-200203150-00022","article-title":"Angiotensin converting enzyme inhibition in chronic allograft nephropathy","volume":"73","author":"Lin","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.03.014_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1399-0012.2004.00315.x","article-title":"Hypertension, antihypertensive agents and outcomes following renal transplantation","volume":"19","author":"Tutone","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2008.03.014_bib15","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/ndt\/gfm310","article-title":"Does size matter?","volume":"22","author":"Heinze","year":"2007","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T05:54:23Z","timestamp":1546062863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134508002170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0041134508002170"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2008.03.014","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}